Journal
JOURNAL OF ECT
Volume 18, Issue 3, Pages 162-164Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00124509-200209000-00009
Keywords
depression; dementia; electroconvulsive therapy; acetylcholinesterase inhibitor; rivastigmine
Categories
Ask authors/readers for more resources
We report the case of an 81-year-old woman, suffering from a major depressive episode and incipient Alzheimer disease, whom we treated with ECT without interrupting therapy with the acetylcholinesterase inhibitor (ACHE-I) rivastigmine. After eight right unilateral ECT sessions, the patient remitted completely without any significant deterioration of memory and cognitive abilities or cholinergic side effects. This report demonstrates that ECT was safely used in one elderly and mildly demented person with continuous ACHE-I therapy. The hypothesis that this drug may indeed protect against unfavorable side effects of ECT should be further tested in clinical trials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available